Aptus Pharma IPO GMP Today ₹ Get the Latest Updates on Aptus Pharma ipo Grey market premium (GMP), Kostak rate, and Subject to Sauda Price along with Expected Listing Gains. Track daily GMP trends and IPO details before investing.
Latest Aptus Pharma IPO GMP (Grey Market Premium)
- Aptus Pharma IPO GMP Today is – ₹- Per Share
- Kostak Rate – Not Available
- Subject to Sauda – ₹-
- Expected Listing Gain – %
Aptus Pharma IPO GMP Price to Down a high to low of ₹0 Rupay on Sep 16 and a High Price of ₹0 on Sep 16, 2025 Showing Strong Market demand.
Aptus Pharma IPO GMP Live – Day-wise Trend ( Table)
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Profit |
|---|---|---|---|---|
| 16-09-2025 | 70.00 | ₹0 | ₹ (0.00%) | ₹0 |
Aptus Pharma IPO Details
| Open Date | Sep 23, 2025 |
|---|---|
| Close Date | Sep 25, 2025 |
| Price Band | ₹65 to ₹70 per share |
| Face Value | ₹10 per equity share |
| Lot Size | 2,000 Shares |
| Minimum Investment | ₹1,40,000 (for 1 lot at ₹70) |
| Type of Issue | Fresh Issue |
| Total Issue Size | 18,60,000 shares (Approx ₹13.02 Cr) |
| Market Maker | 94,000 shares (Approx ₹0.6580 Cr) |
| Net Offered to Public | 17,66,000 shares (Approx ₹12.36 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing Exchange | BSE SME |
| Retail Investor Quota | 33.33% |
| QIB Quota | 47.31% |
| NII (HNI) Quota | 14.30% |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
About Aptus Pharma Limited
Our Company was originally incorporated on June 11, 1999 “Aptus Pharma Limited” engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model. We do not own any manufacturing plants but has entered into contract manufacturing agreement with seven manufacturing units. under various arrangements.
we have formal loan and license agreements in place with two manufacturing units. The remaining production is carried out through informal arrangements with Other manufacturers, based on purchase orders (PO).
We provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipidlowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets,capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels,
and sachets.
our product basket comprises of 194 pharmaceutical formulations in more than eleven (11) therapeutic segments.
We have a distribution network of more than 125 direct and Sub Distributers distributors and a sales team comprising more than 54 field personnel including Medical Representatives (MRs), Area Sales Managers (ASMs), Divisional Sales Managers (DSMs), Regional Sales Managers (RSMs), and a Zonal Manager.
Our product portfolio is structured across four distinct divisions to ensure focused marketing and efficientcoverage of therapeutic segments:
1. Aptus Pharma (Pioneer Division): Focused on acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs etc.
2. Aptus CD Care (Cardiac Diabetic Division): Dedicated to chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering.
3. Aptus Wellcare (Wellcare Division): Offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products.
4. Aptus Global (Export Division): This division is focused on exploring and developing opportunities in overseas markets, particularly in semi-regulated and emerging countries.
Also Read: Aptus Pharma IPO Date, Price, GMP, Review, Details
FAQs ON Aptus Pharma IPO GMP Today
Q1: What is Aptus Pharma IPO GMP today?
Aptus Pharma IPO GMP Price is ₹- Per Share
Q2: What is the Kostak Rate today?
Aptus Pharma IPO Kostak Rate is ₹- as of today Not available.
Q3: Aptus Pharma ipo gmp investorgain?
Aptus Pharma ipo gmp Price investorgain is ₹- rupay Righ Now
Q4: Aptus Pharma ipo gmp ipowatch?
Aptus Pharma ipo gmp ipowatch Price is ₹- rupay Righ Now
Q5: What is the Subject to Sauda rate?
Aptus Pharma IPO Subject to Sauda is ₹- as of today.
Q6: What are the expected listing gains?
Aptus Pharma IPO Estimated % returns based on current GMP
Disclaimer:
IPO GMP (Grey Market Premium), Kostak and Subject to Sauda Rates are Unofficial and Can Change Quickly.
We do Not BUY or SELL IPO Forms.
Do Not apply For IPOs Based only on GMP Price.
Always Review the company’s fundamentals before investing.
